Scancell Holdings PLC (SCLP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

11.00p

Buy

11.50p

arrow-up0.25p (+2.22%)

Prices updated at 01 Apr 2026, 16:22 BST

Prices minimum 15 mins delay

Prices in GBX

Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.

FTSE All-Share

1.9%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	11.50p - 11.00p
	14.00p - 7.80p
	-
	135.95m
	-
	30,000
	791,523
	-
	1,060,363.13
	1.36
	1,036.78m
	GB00B63D3314
	-0.01
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.